Up next

Autoplay

Bentracimab safe to reverse Ticagrelor's effects

1 Views • 08/17/25
Share
Side Effects
Side Effects
Subscribers
0

Bentracimab, an intravenous reversal agent for ticagrelor, has shown immediate and sustained reversal of the Tiacgrelor's antiplatelet effects in both patients undergoing surgery and those with major bleeding, according to a prespecified interim analysis of the REVERSE-IT study presented this week at AHA, 2021.

The drug is a recombinant IgG1 monoclonal antibody fragment that binds to both ticagrelor and its major active circulating metabolite, reversing the antiplatelet effects within 5 minutes.

Previous phase I data in healthy participants, published in 2019, sparked excitement as a potential answer to the challenges faced not just by surgeons, but also by physicians when patients on ticagrelor present with an intracranial hemorrhage, for example, and can't wait the recommended 5 days for the drug's effects to wear off.

For more information, log into:

https://medicaldialogues.in/ca....rdiology-ctvs/news/a

Get the latest medical and heath news at medicaldialogues.in
Follow us on
Twitter: https://twitter.com/medicaldialogs
Facebook: https://www.facebook.com/medicaldialo...
Instagram: https://www.instagram.com/medicaldial...
LinkedIn: https://www.linkedin.com/company/medi...
Website: https://medicaldialogues.in/

Show more
0 Comments sort Sort By

Up next

Autoplay